Skip to navigation Skip to content

News

Share

Society Invests in New MS Research Workforce Awards to Drive Pathways to Cures

September 2, 2021

The National MS Society has approved funding for new research training and early career awards as part of our commitment to support the research workforce. This summer the Society committed over $8.7 million to support 29 new training fellowships, early career awards, and other special initiatives, and continued to lead and support efforts of the International Progressive MS Alliance.
  • Find summaries of these new projects in the latest issue of New Research (.pdf).
The new awards align with the Society’s Pathways to Cures Roadmap:
  • STOPPING MS – achieving a state of no new disease activity, no worsening of daily living or quality of life, and no change in disease manifestations or clinical activity in people living with either relapsing or progressive forms of MS.
  • RESTORING function – translating knowledge from basic mechanisms to functional impact to optimize treatment, manage symptoms, and ultimately restore function for people living with both relapsing and progressive forms of MS.
  • ENDING MS – limiting exposures to MS risk factors in the general population, and developing and deploying interventions in the period prior to preclinical/clinical stages of disease to reduce or eliminate the risk for developing MS.
We remain committed to funding priority research. We will soon be announcing new funding decisions related to our Request for Applications for research proposals focused on early detection of MS. While our usual Research Grant spring and fall cycles and Pilot Research Grants are not yet available, we anticipate offering new research support opportunities over the next few months that advance our Pathways to Cures Roadmap. We expect that these opportunities will align with many of the themes that MS researchers are actively pursuing.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable disease of the central nervous system. Currently there is no cure. Symptoms vary from person to person and may include disabling fatigue, mobility challenges, cognitive changes, and vision issues. An estimated 1 million people live with MS in the United States. Early diagnosis and treatment are critical to minimize disability. Significant progress is being made to achieve a world free of MS.

Share


© 2022 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.